Rituximab in Treating Patients With Multiple Myeloma

NCT00003554 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: rituximab
DRUG: melphalan
DRUG: prednisone

Sponsor

The Cleveland Clinic